ANAPTYSBIO, INC - Common Stock (ANAB)

Q3 2023 13F Holders as of 30 Sep 2023

Type / Class
Equity / Common Stock
Shares outstanding
27,946,194
Total 13F shares
30,319,401
Share change
+85,857
Total reported value
$544,539,672
Put/Call ratio
106%
Price per share
$17.96
Number of holders
116
Value change
-$1,742,551
Number of buys
47
Number of sells
51

Institutional Holders of ANAPTYSBIO, INC - Common Stock (ANAB) as of Q3 2023

As of 30 Sep 2023, ANAPTYSBIO, INC - Common Stock (ANAB) was held by 116 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 30,319,401 shares. The largest 10 holders included EcoR1 Capital, LLC, TANG CAPITAL MANAGEMENT LLC, BlackRock Inc., VANGUARD GROUP INC, Deep Track Capital, LP, Boxer Capital, LLC, BRAIDWELL LP, STATE STREET CORP, Frazier Life Sciences Management, L.P., and GREAT POINT PARTNERS LLC. This page lists 116 institutional shareholders reporting positions in this security for the Q3 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.